Vaccí d'ARN (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaccí d'ARN" in Catalan language version.

refsWebsite

Global rank Catalan rank

12doi.org

2^nd place

6^th place

9nih.gov

4^th place

7^th place

5worldcat.org

5^th place

2phgfoundation.org

low place

2bbc.com

20^th place

66^th place

1sciencedirect.com

149^th place

111^th place

1horizon-magazine.eu

low place

1springer.com

274^th place

287^th place

1jpost.com

544^th place

816^th place

1theguardian.com

12^th place

35^th place

1gov.uk

432^nd place

1,531^st place

1bbc.co.uk

8^th place

26^th place

1wellcome.org

low place

1fullfact.org

low place

1independent.co.uk

36^th place

129^th place

1businessinsider.com

140^th place

561^st place

1nature.com

234^th place

127^th place

bbc.co.uk

«Vaccine rumours debunked: Microchips, 'altered DNA' and more». BBC, 02-12-2020.

bbc.com

«Covid Pfizer vaccine approved for use next week in UK» (en anglès). BBC News, 02-12-2020 [Consulta: 2 desembre 2020].
«Vaccine rumours debunked: Microchips, 'altered DNA' and more» (en anglès). BBC News, 02-12-2020.

businessinsider.com

Bendix, Susie Neilson, Andrew Dunn, Aria. «Moderna's groundbreaking coronavirus vaccine was designed in just 2 days». [Consulta: 11 desembre 2020].

doi.org

dx.doi.org

«Non-viral COVID-19 vaccine delivery systems» (en anglès). Advanced Drug Delivery Reviews, 169, 01-02-2021, pàg. 137–151. DOI: 10.1016/j.addr.2020.12.008. ISSN: 0169-409X. PMC: PMC7744276. PMID: 33340620.
Verbeke, Rein; Lentacker, Ine; De Smedt, Stefaan C.; Dewitte, Heleen «Three decades of messenger RNA vaccine development». Nano Today, 28, 10-2019, pàg. 100766. DOI: 10.1016/j.nantod.2019.100766.
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery, 17, 4, 4-2018, pàg. 261–279. DOI: 10.1038/nrd.2017.243. PMC: 5906799. PMID: 29326426.
«Introduction to RNA Vaccines». A: RNA Vaccines: Methods and Protocols. 1499, 2017, p. 1–11. DOI 10.1007/978-1-4939-6481-9_1. ISBN 978-1-4939-6479-6 [Consulta: 18 novembre 2020].
«COVID-19 vaccines poised for launch, but impact on pandemic unclear». Nature Biotechnology, 11-2020. DOI: 10.1038/d41587-020-00022-y. PMID: 33239758.
Karikó, Katalin; Buckstein, Michael; Ni, Houping; Weissman, Drew «Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA». Immunity, 23, 2, 8-2005, pàg. 165–175. DOI: 10.1016/j.immuni.2005.06.008. ISSN: 1074-7613. PMID: 16111635.
Karikó, Katalin; Muramatsu, Hiromi; Ludwig, János; Weissman, Drew «Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA». Nucleic Acids Research, 39, 21, 02-09-2011, pàg. e142. DOI: 10.1093/nar/gkr695. ISSN: 1362-4962. PMC: 3241667. PMID: 21890902.
Pardi, Norbert; Weissman, Drew. Nucleoside Modified mRNA Vaccines for Infectious Diseases. 1499. Springer New York, 2016-12-17, p. 109–121. DOI 10.1007/978-1-4939-6481-9_6. ISBN 978-1-4939-6479-6.
Schlake, Thomas; Thess, Andreas; Fotin-Mleczek, Mariola; Kallen, Karl-Josef «Developing mRNA-vaccine technologies». RNA Biology, 9, 11, 11-2012, pàg. 1319–1330. DOI: 10.4161/rna.22269. ISSN: 1547-6286. PMC: 3597572. PMID: 23064118.
Berglund, Peter «Enhancing immune responses using suicidal DNA vaccines». Nature Biotechnology, 16, 6, 6-1998, pàg. 562–5. DOI: 10.1038/nbt0698-562. PMID: 9624688.
Vogel, Annette B.; Lambert, Laura; Kinnear, Ekaterina; Busse, David; Erbar, Stephanie; Reuter, Kerstin C.; Wicke, Lena; Perkovic, Mario; Beissert, Tim «Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses». Molecular Therapy, 26, 2, 2-2018, pàg. 446–455. DOI: 10.1016/j.ymthe.2017.11.017. ISSN: 1525-0016. PMC: 5835025. PMID: 29275847.
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery, 17, 4, 4-2018, pàg. 261–279. DOI: 10.1038/nrd.2017.243. PMC: 5906799. PMID: 29326426.

fullfact.org

«RNA Covid-19 vaccines will not change your DNA» (en anglès), 30-11-2020. [Consulta: 11 desembre 2020].

gov.uk

«Conditions of Authorisation for Pfizer/BioNTech COVID-19 Vaccine». Medicines & Healthcare Products Regulatory Agency, 08-12-2020.

horizon-magazine.eu

Roberts, Joanna (2020-06-01). «Five things you need to know about: mRNA vaccines». Horizon. Consulta: 2020-11-16.

independent.co.uk

«'What is Covid vaccine made of?' trends on Google as Pfizer and Moderna seek FDA approval». , 18-11-2020.

jpost.com

«Could mRNA COVID-19 vaccines be dangerous in the long-term?». , 17-11-2020.

nature.com

«COVID-19 vaccines poised for launch, but impact on pandemic unclear». Nature Biotechnology, 11-2020. DOI: 10.1038/d41587-020-00022-y. PMID: 33239758.

nih.gov

ncbi.nlm.nih.gov

«Non-viral COVID-19 vaccine delivery systems» (en anglès). Advanced Drug Delivery Reviews, 169, 01-02-2021, pàg. 137–151. DOI: 10.1016/j.addr.2020.12.008. ISSN: 0169-409X. PMC: PMC7744276. PMID: 33340620.
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery, 17, 4, 4-2018, pàg. 261–279. DOI: 10.1038/nrd.2017.243. PMC: 5906799. PMID: 29326426.
«COVID-19 vaccines poised for launch, but impact on pandemic unclear». Nature Biotechnology, 11-2020. DOI: 10.1038/d41587-020-00022-y. PMID: 33239758.
Karikó, Katalin; Buckstein, Michael; Ni, Houping; Weissman, Drew «Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA». Immunity, 23, 2, 8-2005, pàg. 165–175. DOI: 10.1016/j.immuni.2005.06.008. ISSN: 1074-7613. PMID: 16111635.
Karikó, Katalin; Muramatsu, Hiromi; Ludwig, János; Weissman, Drew «Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA». Nucleic Acids Research, 39, 21, 02-09-2011, pàg. e142. DOI: 10.1093/nar/gkr695. ISSN: 1362-4962. PMC: 3241667. PMID: 21890902.
Schlake, Thomas; Thess, Andreas; Fotin-Mleczek, Mariola; Kallen, Karl-Josef «Developing mRNA-vaccine technologies». RNA Biology, 9, 11, 11-2012, pàg. 1319–1330. DOI: 10.4161/rna.22269. ISSN: 1547-6286. PMC: 3597572. PMID: 23064118.
Berglund, Peter «Enhancing immune responses using suicidal DNA vaccines». Nature Biotechnology, 16, 6, 6-1998, pàg. 562–5. DOI: 10.1038/nbt0698-562. PMID: 9624688.
Vogel, Annette B.; Lambert, Laura; Kinnear, Ekaterina; Busse, David; Erbar, Stephanie; Reuter, Kerstin C.; Wicke, Lena; Perkovic, Mario; Beissert, Tim «Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses». Molecular Therapy, 26, 2, 2-2018, pàg. 446–455. DOI: 10.1016/j.ymthe.2017.11.017. ISSN: 1525-0016. PMC: 5835025. PMID: 29275847.
Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.; Weissman, Drew «mRNA vaccines — a new era in vaccinology». Nature Reviews Drug Discovery, 17, 4, 4-2018, pàg. 261–279. DOI: 10.1038/nrd.2017.243. PMC: 5906799. PMID: 29326426.

phgfoundation.org

PHG Foundation. «RNA vaccines: an introduction», 2019. [Consulta: 18 novembre 2020].
«RNA vaccines: an introduction». [Consulta: 13 abril 2020].

sciencedirect.com

«Non-viral COVID-19 vaccine delivery systems» (en anglès). Advanced Drug Delivery Reviews, 169, 01-02-2021, pàg. 137–151. DOI: 10.1016/j.addr.2020.12.008. ISSN: 0169-409X. PMC: PMC7744276. PMID: 33340620.

springer.com

link.springer.com

«Introduction to RNA Vaccines». A: RNA Vaccines: Methods and Protocols. 1499, 2017, p. 1–11. DOI 10.1007/978-1-4939-6481-9_1. ISBN 978-1-4939-6479-6 [Consulta: 18 novembre 2020].

theguardian.com

«UK approves Pfizer/BioNTech Covid vaccine for rollout next week». , 02-12-2020.

wellcome.org

«Seven vital questions about the RNA Covid-19 vaccines emerging from clinical trials | News | Wellcome». [Consulta: 11 desembre 2020].

worldcat.org

«Non-viral COVID-19 vaccine delivery systems» (en anglès). Advanced Drug Delivery Reviews, 169, 01-02-2021, pàg. 137–151. DOI: 10.1016/j.addr.2020.12.008. ISSN: 0169-409X. PMC: PMC7744276. PMID: 33340620.
Karikó, Katalin; Buckstein, Michael; Ni, Houping; Weissman, Drew «Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA». Immunity, 23, 2, 8-2005, pàg. 165–175. DOI: 10.1016/j.immuni.2005.06.008. ISSN: 1074-7613. PMID: 16111635.
Karikó, Katalin; Muramatsu, Hiromi; Ludwig, János; Weissman, Drew «Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA». Nucleic Acids Research, 39, 21, 02-09-2011, pàg. e142. DOI: 10.1093/nar/gkr695. ISSN: 1362-4962. PMC: 3241667. PMID: 21890902.
Schlake, Thomas; Thess, Andreas; Fotin-Mleczek, Mariola; Kallen, Karl-Josef «Developing mRNA-vaccine technologies». RNA Biology, 9, 11, 11-2012, pàg. 1319–1330. DOI: 10.4161/rna.22269. ISSN: 1547-6286. PMC: 3597572. PMID: 23064118.
Vogel, Annette B.; Lambert, Laura; Kinnear, Ekaterina; Busse, David; Erbar, Stephanie; Reuter, Kerstin C.; Wicke, Lena; Perkovic, Mario; Beissert, Tim «Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses». Molecular Therapy, 26, 2, 2-2018, pàg. 446–455. DOI: 10.1016/j.ymthe.2017.11.017. ISSN: 1525-0016. PMC: 5835025. PMID: 29275847.